Never miss an important update

Click    to get notified about important updates only.   

99 push-notification-bg

99 Alternatives

We are sorry that you have opted out.

However, if you accidentally selected "Block" or you want to receive notifications in the future, then follow any of the following instructions.

Option 1

99 chrome-b-n

Option 2

1. visit to Chrome > Settings > Content Settings

2. click here Content Settings > Notifications > Manage Exceptions

OR

Copy & Paste in Addrsss Bar > "chrome://settings/content/notifications?search=notif"

3. Select Allow for https://www.99alternatives.com/

4. Refresh the page.

99 Alternatives

Opportunities are Infinite

Please wait
99 Alternative logo
Business
All Categories

Investors Space-Spreading Awareness

Join a community that's informative, communicative & Interactive

99 Alternatives-Taking Initiative

99 top-hearder-guide-book
Register Today to Download Your Free
Alternative Asset Guide for 2020
Worth £49.99 and Free Life Time
Subscription to 99 Alternatives Web Portal
Worth £100's Limited Availability…
register for e Asset Guide
Latest News
Oil falls as rising virus cases overshadow demand recovery
UK clears Amazon deal to buy 16% stake in online food platform Deliveroo
German regulator tenders for 4,000 MW of hard coal plant closures
Dixons Carphone says to cut 800 jobs in its UK and Ireland stores
Microsoft's rescue attempt of TikTok endears old company to new generation
Booking.com wants to lay off a quarter of its staff - NRC Handelsblad
Scam Alerts
What Is The Computer Misuse Act?
Call Centre Scams Conning People
The easy way to stop your online accounts getting hacked
Fraudster sentenced after funding luxury holidays through £50k smishing scam
Banking industry stops £4.5 million of fraud a day in first half of 2019
Barclays issues warning to university students, as number of under-21s recruited as money mules..
728x9099 Ads

Roche aims to 'underwhelm' on SMA drug price to challenge rivals

99 ALternatives News Pic
Share:
ZURICH/SAN FRANCISCO (Reuters) - Swiss drugmaker Roche plans to price its oral spinal muscular atrophy drug (SMA) risdiplam aggressively to challenge two of the world's most expensive medicines, Biogen's Spinraza and Novartis's gene therapy Zolgensma. Spinraza's list price is $750,000 in the first year, and $375,000 thereafter, while Novartis's gene therapy for the genetic muscle wasting..
Date Published: Jan 14, 2020
To view the full article, Register Now.
Register Today And Get Your Free Lifetime Elite Subscription Worth £100’s
Are You Already a Member? Login
Natex_728x9099 Ads

Related Articles

300x25099 Ads

Video

Copyright © 2020 99alternatives Ltd.   All rights reserved.

Designed and Managed by Mont Digital